Progyny Stock - Weekly review and fertility benefits backdrop
19.06.2026 - 19:17:03 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 19:14 CET. Details in the imprint.
Progyny (US74340E1038) is ending the week without major corporate headlines, but the fertility-benefits specialist still sits in a volatile corner of the US health-care market. The focus for investors this Friday is how the stock stacks up against peers after recent moves.
All news and data on Progyny stock
Key figures, company announcements and market data for Progyny stock can be found bundled on the ad hoc news topic page and on the company’s investor-relations site.
How Progyny ended the week
With no fresh investor-relations releases on 06/19/2026, the market’s attention has centered on how Progyny shares have traded since its latest quarterly report in early May. That update showed continued revenue growth and highlighted new client wins in fertility benefits.
On balance, the shares have moved in line with a broader mix of US health-care services stocks over recent weeks, with sentiment driven more by interest-rate expectations and risk appetite than by company-specific catalysts. The name remains a mid-cap component within the US health-care space rather than a benchmark index heavyweight.
Sector comparison this Friday
This Friday’s sector view still places Progyny alongside other benefits and managed-care names that serve large employers and health plans. Many of these companies have seen relatively robust fundamentals, supported by recurring revenue from long-term contracts.
Compared with traditional insurers and diversified health platforms, Progyny’s focus on fertility and family-building benefits makes its revenue base more concentrated, but also gives it exposure to a structurally growing niche. Overall, investors this week have been weighing the trade-off between higher growth potential and more specialized risk.
How the company makes money
Progyny generates revenue by managing fertility and family-building benefits for employers and health plans, bundling clinical services, pharmacy benefits and patient support. It typically charges fees linked to the benefits program while coordinating with a network of fertility clinics and pharmacies.
Where the stock trades today
The shares of Progyny (US74340E1038) trade on Nasdaq around the mid-$20 range as of 06/19/2026, 19:14 CET, based on recent market data converted to Central European Time.
Progyny at a glance
- Company: Progyny Inc.
- ISIN: US74340E1038
- Ticker: PGNY
- Venue: Nasdaq
- Price (as of 06/19/2026, 19:14 CET): mid-$20 range USD
- Sector / Industry: Health Care / Managed care & benefits
- Index membership: US mid-cap health-care universe
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
